Medical Clinic, Psychosomatics, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, German Center for Cardiovascular Research, Partner Site Berlin, Germany.
Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
J Psychosom Res. 2021 Dec;151:110659. doi: 10.1016/j.jpsychores.2021.110659. Epub 2021 Oct 28.
INTRODUCTION: A hyper-coagulant state is a biological mechanism that triggers cardiac events in patients with coronary artery disease (CAD). Depressive symptoms and anxiety predict an unfavourable course of CAD. The SPIRR-CAD-RCT examined the effects of a psychological intervention and provided the opportunity to explore cross-sectional associations between indices of psychological strain and coagulation parameters, as well as prospective changes in depression scores and coagulation parameters. METHODS: In this secondary analysis, we investigated 253 CAD patients (194 male; age m 58.9, SD 8.3 yrs.) with mild to moderate depression (≥8 on the HADS-D) at baseline and at follow-up 18 months later: TF, fibrinogen, D-dimer, VWF, FVII and PAI-1 and the course of depression (HAM-D), vital exhaustion (VE) and anxiety scores (HADS-A) were examined by ANOVA in the total and younger age groups (≤ 60). RESULTS: HAM-D at baseline was correlated with TF (corr. R = 0.27; F = 9.31, p = 0.001). HADS anxiety was associated with fibrinogen (corr. R.20; F = 7.27, p = 0.001). There was no detectable therapeutic effect on coagulation. Fibrinogen and VWF decreased within 18 months (time effect; p = 0.02; p = 0.04), as did HADS-D in both treatment groups (p < 0.001). Fibrinogen decreased more in patients ≤60 years with high VE compared to low VE (interaction time x group, p = 0.01). CONCLUSIONS: This is the first study to show an association between TF and depression. Coagulation parameters as potential mediators of CAD progression correlated cross-sectionally with depression and anxiety and prospectively with VE. Further studies should replicate these correlations in depressed and non-depressed CAD patients. ISRCTN: 76240576; clinicaltrials.gov.
简介:高凝状态是触发冠心病(CAD)患者心脏事件的生物学机制。抑郁症状和焦虑预示着 CAD 病程不佳。SPIRR-CAD-RCT 研究了心理干预的效果,并提供了机会来探讨心理压力指数与凝血参数之间的横断面关联,以及抑郁评分和凝血参数的前瞻性变化。
方法:在这项二次分析中,我们调查了 253 名基线时有轻度至中度抑郁(HADS-D 评分≥8)的 CAD 患者(194 名男性;年龄均为 58.9 岁,标准差为 8.3 岁),并在 18 个月后进行随访:TF、纤维蛋白原、D-二聚体、vWF、FVII 和 PAI-1 以及抑郁(HAMD)的病程、活力衰竭(VE)和焦虑评分(HADS-A)通过方差分析在总人群和年龄较小的人群(≤60 岁)中进行了检查。
结果:基线时的 HAMD 与 TF 相关(相关 R=0.27;F=9.31,p=0.001)。HADS 焦虑与纤维蛋白原相关(相关 R.20;F=7.27,p=0.001)。在凝血方面没有发现可检测到的治疗效果。纤维蛋白原和 vWF 在 18 个月内下降(时间效应;p=0.02;p=0.04),两个治疗组的 HADS-D 也下降(p<0.001)。VE 较高的患者≤60 岁的纤维蛋白原下降幅度大于 VE 较低的患者(时间与组的交互作用,p=0.01)。
结论:这是第一项表明 TF 与抑郁相关的研究。凝血参数作为 CAD 进展的潜在介质,与抑郁和焦虑呈横断面相关,与 VE 呈前瞻性相关。进一步的研究应该在抑郁和非抑郁的 CAD 患者中复制这些相关性。
ISRCTN:76240576;clinicaltrials.gov。
Psychoneuroendocrinology. 2018-6-4
J Psychosom Res. 2017-12-5